"Science" big news! The secret of longevity that can live for 200 years was found deep in the ocean!
Release time:
2021-11-19
For natural life, aging and death are inevitable. A common hallmark of aging is that cells slowly lose their ability to produce new, healthy cells to repair damage.
However, as both vertebrates, some Pacific rockfish can live for more than 200 years, while others can only live for about 10 years. The life span of the two differs by 20 times! This also makes the former one of the longest-lived vertebrates. This difference in lifespan has attracted keen interest among scientists.

Recently, "Science" magazine revealed to us the mystery behind this longevity in the form of a cover paper.
Scientists from the University of California, Berkeley, collected tissue samples from 88 species of rockfish and performed whole-genome sequencing. The study found that long-lived rockfish groups contain abundant DNA repair pathways and 137 longevity-related genes. It affects lifespan directly through effects on insulin signaling and other pathways, and indirectly through effects on size and environmental adaptability.
We know that when organisms age, DNA damage will continue to accumulate, and these damages may further accelerate the aging process. If these damaged DNA can be repaired in time, the genome can be maintained in a "young state" and aging can be delayed.

▲Different rockfish have different sizes and lifespans
At the same time, scientists say that if you want to live longer, it depends on your environment. They found that rockfish that are larger and live in deeper, colder waters have slower metabolisms and are less susceptible to illness from microbial infections, which are associated with longer lifespans.
The research was published in the top international academic journal Science on November 11, 2021, titled: Origins and evolution of extreme life span in Pacific Ocean rockfishes.

Scientists hope that long-lived rockfish can provide humans with strategies to improve longevity. Strategies to improve DNA repair and control inflammation may extend lifespan and healthspan.
Articles compiled from the Internet
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.